Exploring the Future of Rare Bleeding Disorder Treatment at EHC 2026
European Haemophilia Consortium (EHC) shared a post on LinkedIn:
“Reminder to EHC National Member Organisations (NMOs): registration for the EHC New Technologies Conference 2026 is still open!
Joining us in Bucharest, Romania, from 30 October to 1 November 2026, this conference will bring together EHC NMOs and healthcare professionals for an in-depth look at the latest medical advancements in rare bleeding disorders, including the new technologies set to reach the European market in the coming years.
Places are limited to two representatives per NMO on a first-come, first-served basis.
EHC will cover registration, travel (economy fare), and accommodation costs for participants nominated by NMOs.
The registration link has been sent directly to NMOs by email.
Haven’t registered yet?
Act now — spots are filling up!
Full event details.”
Stay updated with Hemostasis Today.
-
Nov 15, 2026, 10:32Ibrahim Gwarzo: Identifying Care Gaps and Emergency Pain Delays in Sickle Cell Disease at APHA 2026
-
Nov 15, 2026, 10:17Ify Osunkwo: How the Sickle Cell Community Can Influence FDA Drug Development Priorities
-
Nov 15, 2026, 10:11Ahmed Abdelsalam: Why Matching ABO and RhD Groups Does Not Guarantee Crossmatch Compatibility
-
Nov 15, 2026, 10:06Asma Khalil: New British Society for Haematology Guidance on Paediatric and Neonatal Transfusion
-
Nov 15, 2026, 09:41Girishkumar Modi: Navigating the 2026 Jehovah’s Witness Transfusion Policy Shift in Clinical Practice
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis